These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 16377145)

  • 21. Active control comparisons: the ideal trial design.
    Brodie MJ; Whitehead J
    Epilepsy Res; 2006 Jan; 68(1):69-73. PubMed ID: 16377147
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcomes research: clinical trials in the elderly.
    Leppik IE; Brodie MJ; Saetre ER; Rowan AJ; Ramsay RE; Macias F; Jacobs MP
    Epilepsy Res; 2006 Jan; 68 Suppl 1():S71-6. PubMed ID: 16413171
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alternatives to randomized clinical trials.
    Ellison GW; Mickey MR; Myers LW
    Neurology; 1988 Jul; 38(7 Suppl 2):73-5. PubMed ID: 3290718
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monotherapy in children and infants.
    Wilfong AA
    Neurology; 2007 Dec; 69(24 Suppl 3):S17-22. PubMed ID: 18071153
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Randomization as a basis for inference in noninferiority trials.
    Wiens BL
    Pharm Stat; 2006; 5(4):265-71. PubMed ID: 17128425
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical trial design for mild-to-moderate community-acquired pneumonia--an industry perspective.
    Echols RM; Tillotson GS; Song JX; Tosiello RL
    Clin Infect Dis; 2008 Dec; 47 Suppl 3():S166-75. PubMed ID: 18986284
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recommendations of the Italian League against Epilepsy working group on generic products of antiepileptic drugs.
    Perucca E; Albani F; Capovilla G; Bernardina BD; Michelucci R; Zaccara G
    Epilepsia; 2006; 47 Suppl 5():16-20. PubMed ID: 17239100
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Refractory epilepsy: clinical overview.
    French JA
    Epilepsia; 2007; 48 Suppl 1():3-7. PubMed ID: 17316406
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcomes in elderly patients with newly diagnosed and treated epilepsy.
    Brodie MJ; Stephen LJ
    Int Rev Neurobiol; 2007; 81():253-63. PubMed ID: 17433929
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A long-term follow-up of zonisamide monotherapy.
    Fukushima K; Seino M
    Epilepsia; 2006 Nov; 47(11):1860-4. PubMed ID: 17116025
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy.
    Perucca E; Cloyd J; Critchley D; Fuseau E
    Epilepsia; 2008 Jul; 49(7):1123-41. PubMed ID: 18503564
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Choosing the analysis population in non-inferiority studies: per protocol or intent-to-treat.
    Matilde Sanchez M; Chen X
    Stat Med; 2006 Apr; 25(7):1169-81. PubMed ID: 16397861
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Seizure-free outcome in randomized add-on trials of the new antiepileptic drugs.
    Gazzola DM; Balcer LJ; French JA
    Epilepsia; 2007 Jul; 48(7):1303-7. PubMed ID: 17521343
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bayesian approach to assay sensitivity analysis of thorough QT trials.
    Dong X; Ding X; Tsong Y
    J Biopharm Stat; 2013; 23(1):73-81. PubMed ID: 23331222
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of major antiepileptic drugs on attention, reaction time, and speed of information processing: results from a randomized, double-blind, placebo-controlled withdrawal study of seizure-free epilepsy patients receiving monotherapy.
    Hessen E; Lossius MI; Reinvang I; Gjerstad L
    Epilepsia; 2006 Dec; 47(12):2038-45. PubMed ID: 17201701
    [TBL] [Abstract][Full Text] [Related]  

  • 37. First-drug treatment failures in children newly diagnosed with epilepsy.
    Dudley RW; Penney SJ; Buckley DJ
    Pediatr Neurol; 2009 Feb; 40(2):71-7. PubMed ID: 19135617
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypotheses and type I error in active-control noninferiority trials.
    Chen G; Wang YC; Chi GY
    J Biopharm Stat; 2004 May; 14(2):301-13. PubMed ID: 15206528
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Monotherapy trials.
    Garofalo EA
    Adv Neurol; 1998; 76():133-41. PubMed ID: 9408470
    [No Abstract]   [Full Text] [Related]  

  • 40. When to start drug treatment for childhood epilepsy: the clinical-epidemiological evidence.
    Arts WF; Geerts AT
    Eur J Paediatr Neurol; 2009 Mar; 13(2):93-101. PubMed ID: 18567515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.